Tatva Chintan Pharma Chem Limited
NSE:TATVA.NS
856.35 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||
Net Income
| 52.09 | 96.14 | 34.55 | 77.81 | 95.04 | 169.59 | 116.23 | 71.12 | 97.97 | 175.1 | 228.07 | 324.12 | 231.46 | 211.19 | 208.75 | 35.56 | 67.1 |
Depreciation & Amortization
| 0 | 0 | 65.83 | 67.77 | 60.12 | 25.31 | 23.83 | 23.08 | 0 | 0 | 0 | 0 | 0 | 17.6 | 0 | 0 | 0 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -338.13 | 0 | 0 | 0 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -333.21 | 0 | 0 | 0 |
Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.75 | 0 | 0 | 0 |
Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.83 | 0 | 0 | 0 |
Other Non Cash Items
| -52.09 | -96.14 | -34.55 | -77.81 | -95.04 | -169.59 | -116.23 | -71.12 | -97.97 | -175.1 | -228.07 | -324.12 | -231.46 | 78.68 | -208.75 | -35.56 | -67.1 |
Operating Cash Flow
| 0 | 0 | 131.66 | 135.54 | 120.24 | 50.62 | 47.66 | 46.16 | 0 | 0 | 0 | 0 | 0 | -30.66 | 0 | 0 | 0 |
Investing Activities: | |||||||||||||||||
Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -103.31 | 0 | 0 | 0 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.9 | 0 | 0 | 0 |
Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -104.21 | 0 | 0 | 0 |
Financing Activities: | |||||||||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -32.44 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 127.6 | 0 | 0 | 0 |
Financing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95.16 | 0 | 0 | 0 |
Other Information: | |||||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 84.52 | 0 | 0 | 0 |
Net Change In Cash
| 0 | 0 | 131.66 | 135.54 | 120.24 | 50.62 | 47.66 | 46.16 | 0 | 0 | 0 | 0 | 0 | 44.81 | 0 | 0 | 0 |
Cash At End Of Period
| 0 | 0 | 1,569.14 | 1,437.48 | 429.35 | 309.11 | 934.47 | 886.81 | 0 | 0 | 0 | 0 | 44.81 | 44.81 | 0 | 0 | 0 |